First-of-its-Kind COVID-19 Home Test Gets FDA Authorization

Cue Health’s over-the-counter molecular nucleic acid amplification test (NAAT) for COVID-19 has been granted FDA de novo authorization, making it the first traditionally authorized at-home test for any respiratory illness.
Source: Drug Industry Daily